Biotech Values

[oldberkeley]

I could also see Teva suing the FDA in that situation...

Win or lose, that strategy always makes me consider the creation of some sort of "goodwill deficit."

Certainly Copaxone is hugely important to Teva, but as the largest generic drug manufacturer and one of the largest pharma companies in the world, they're going to have to work with the FDA on many, many other drugs in the future.